Lundbeck
HLUN-B.CO
#2587
Rank
ยฃ4.31 B
Marketcap
ยฃ4.52
Share price
-1.88%
Change (1 day)
21.64%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): ยฃ0.29

According to Lundbeck 's latest financial reports the company's current EPS (TTM) is ยฃ0.28. In 2022 the company made an earnings per share (EPS) of ยฃ0.21 a decrease over its 2021 EPS that were of ยฃ0.48.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ0.2938.45%
2022ยฃ0.21-55.47%
2021ยฃ0.48-51.83%
2020ยฃ0.99-28.01%
2019ยฃ1.37-44.08%
2018ยฃ2.4551.94%
2017ยฃ1.61126.64%
2016ยฃ0.71-120.84%
2015-ยฃ3.425622.18%
2014-ยฃ0.05972-110.03%
2013ยฃ0.60-28.08%
2012ยฃ0.83-52.1%
2011ยฃ1.73-1.31%
2010ยฃ1.7515.61%
2009ยฃ1.51